Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic avenues for γδ T cells in cancer
Gonçalo Palrão Costa, Sofia Mensurado, Bruno Silva‐Santos
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 11, pp. e007955-e007955
Open Access | Times Cited: 13

Showing 13 citing articles:

Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 Regimen
Richard E. Kast
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 153-153
Open Access
γδ T Cells: Game Changers in Immune Cell Therapy for Cancer
Nabil Subhi‐Issa, Daniel Tovar Manzano, A. Rodríguez, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1063-1063
Open Access
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity
Lola Boutin, Mingzhi Liu, Julie Déchanet‐Merville, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Targeting B7-H3 inhibition-induced activation of fatty acid synthesis boosts anti-B7-H3 immunotherapy in triple-negative breast cancer
Ying Jiang, Zhiwen Qian, C Wang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010924-e010924
Open Access
Harnessing γδ T Cells against Human Gynecologic Cancers
José R. Conejo-García, Carmen M. Anadon, Luis Lopez‐Bailon, et al.
Life (2024) Vol. 14, Iss. 3, pp. 325-325
Open Access | Times Cited: 2
Tuning CAR T-cell therapies for efficacy and reduced toxicity
Danielle Blud, Patricia Rubio-Reyes, Rachel Perret, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 333-344
Closed Access | Times Cited: 2
Analysis of the Effector Functions of Vδ2 γδ T Cells and NK Cells against Cholangiocarcinoma Cells
Inthuon Kulma, Kesara Na‐Bangchang, Andrea Carvallo Herrera, et al.
Cells (2024) Vol. 13, Iss. 16, pp. 1322-1322
Open Access | Times Cited: 1
Pan-cancer γδ TCR analysis uncovers clonotype diversity and prognostic potential
Xiaoqing Yu, Li Song, Ling Cen, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 10, pp. 101764-101764
Open Access | Times Cited: 1
Participation and Role of γδT Cells in the Occurrence and Development of Autoimmune Diseases
晨夕 李
Pharmacy Information (2024) Vol. 13, Iss. 04, pp. 362-368
Closed Access
A pan-cancer gamma delta T cell repertoire
Xiaoqing Yu, Li Song, Ling Cen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Key actors in neuropathophysiology: The role of γδ T cells
Deniz Bulgur, Raquel Macedo Moura, Julie C. Ribot
European Journal of Immunology (2024) Vol. 54, Iss. 12
Open Access
Ephrin-A2 and Phosphoantigen-Mediated Selective Killing of Medulloblastoma by γδT Cells Preserves Neuronal and Stem Cell Integrity
Lola Boutin, Mingzhi Liu, Julie Déchanet Merville, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Engineered Cellular Therapies for the Treatment of Thoracic Cancers
Spencer M Erickson, Benjamin M. Manning, Akhilesh Kumar, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 35-35
Open Access
Page 1

Scroll to top